Immunicum AB (publ) Announces Upcoming Oral Presentation on MERECA Trial at the ASCO-SITC Clinical Immuno-Oncology Symposium 20 December 2019 Read more
Immunicum AB (publ) Announces Positive Preclinical Data on Ilixadencel in Combination with CTLA-4 Immune Checkpoint Inhibitor 21 October 2019 Read more
Immunicum AB (publ) Announces Advancement to Next Dosage Group Level in Phase Ib/II ILIAD Combination Trial 1 October 2019 Read more
Immunicum AB (publ) Announces Complete Topline Data Analysis from Phase II MERECA Trial 25 September 2019 Read more R
Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients 29 August 2019 Read more R
Immunicum AB (publ) Announces New Issuance Date for Interim Report April – June 2019 and Corporate Update Event 28 June 2019 Read more R
Immunicum AB (publ) Announces Positive Topline Results from the Phase I/II Clinical Trial in GIST 12 June 2019 Read more
Immunicum AB (publ) Announces Outcome of Subscription in Employee Incentive Program 2019/2022 28 May 2019 Read more
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019 25 April 2019 Read more
Immunicum AB (publ) Announces First Patient Treated in Phase Ib/II ILIAD Combination Trial 11 February 2019 Read more
Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Rights Issue 31 January 2019 Read more R
Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology 21 January 2019 Read more
Immunicum AB (publ) Announces Complete Topline Data Analysis from Phase II MERECA Trial 25 September 2019 Read more R
Immunicum AB (publ) Announces Positive Phase II MERECA Topline Results Including Complete Tumor Responses in Metastatic Renal Cell Carcinoma Patients 29 August 2019 Read more R
Immunicum AB (publ) Announces New Issuance Date for Interim Report April – June 2019 and Corporate Update Event 28 June 2019 Read more R
Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Rights Issue 31 January 2019 Read more R
